These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15119033)

  • 1. Engineering and validation of recombinant proteins for allergen vaccines.
    Spangfort MD
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):151-4; discussion 155. PubMed ID: 15119033
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypothesis--Peptide library generated by cathepsin S might be efficacious for allergen-specific immunotherapy.
    Li C; Jiang Y; Li L
    Vaccine; 2010 Feb; 28(5):1135-7. PubMed ID: 19948264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological engineering for new asthma therapy].
    Van Hage M; Grönlund H; Gafvelin G
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1942-5. PubMed ID: 18681377
    [No Abstract]   [Full Text] [Related]  

  • 5. Engineering allergens.
    Mutschlechner S; Ferreira F
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):226-9. PubMed ID: 17124778
    [No Abstract]   [Full Text] [Related]  

  • 6. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
    Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F
    Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular approaches for new vaccines against allergy.
    Niederberger V; Valenta R
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vaccines and adjuvants for allergen-specific immunotherapy.
    Crameri R; Rhyner C
    Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of allergic diseases by means of allergens and vaccines of domestic production].
    Kruczalowa M; Weiss A
    Pol Tyg Lek; 1968 Mar; 23(11):405-6. PubMed ID: 5668776
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic and specific treatment for a global disease: allergen immunotherapy revisited.
    Kowalski ML
    Allergy; 2006 Jul; 61(7):791-5. PubMed ID: 16792575
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparing and mixing allergen vaccines.
    Nelson HS
    Clin Allergy Immunol; 2004; 18():457-79. PubMed ID: 15042929
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL; Singh MB
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
    Wild C; Wallner M; Hufnagl K; Fuchs H; Hoffmann-Sommergruber K; Breiteneder H; Scheiner O; Ferreira F; Wiedermann U
    Allergy; 2007 Jan; 62(1):33-41. PubMed ID: 17156339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of recombinant allergens and epitopes.
    Bousquet J
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):257-62. PubMed ID: 7532947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.